Research Triangle Park, NC – August 2, 2004 - EPZICOM TM, a new product combining two HIV medicines into one tablet dosed once a day (QD) with no food or fluid requirements, was cleared for ...
The Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for Epzicom (abacavir sulfate and lamivudine; GlaxoSmithKline) for once-daily dosing in pediatric ...
Generic competition for GlaxoSmithKline (NYSE:GSK) AIDS drug Epzicom is on its way around the world, if not the United States. Yet. The U.S. Food and Drug Administration has given tentative approval ...
To earn CME related to this news article, click here. This activity is part of an ongoing CME/CE initiative to provide information on labeling changes reported by the FDA. Activities of this nature ...
A study released on World AIDS Day reports that viral failure, the point at which medication can no longer suppress the HIV infection, was twice as likely and happened sooner among patients initiating ...
Please provide your email address to receive an email when new articles are posted on . Combination ART regimens built on a backbone of Epzicom may reduce the progression of liver fibrosis among ...
Mumbai, April 4 (IANS) Global pharmaceutical company Cipla on Tuesday announced that it has received final approval of the US Food and Drug Administration (USFDA) for the generic version of Epzicom ...
Medicare Part D plans would have saved more than $925 million in 2016 by prescribing generic instead of brand-name versions of combination drugs, according to a new study in The Journal of the ...
Cipla on Tuesday said it it has received final approval from US FDA to sell generic version of Epzicom tablets in US. Epzicom, a combination of Abacavir and Lamivudine Tablets USP, 600 mg/300 mg, are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results